XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues [Abstract]      
Revenues $ 450,712 $ 331,412 $ 270,827
Expenses:      
Cost of product sales 12,269 4,481 6,408
Research and development 174,638 216,566 253,297
Selling, general and administrative 266,132 213,894 159,371
Royalty 216 180 186
Total operating expenses 453,255 435,121 419,262
Loss from operations (2,543) (103,709) (148,435)
Interest income 14,746 15,777 5,127
Interest expense (98,516) (108,239) (99,092)
Loss on extinguishment of debt 0 (29,019) 0
Foreign currency losses, net (641) (1,039) (1,983)
Total other expense (84,411) (122,520) (95,948)
Loss before income taxes (86,954) (226,229) (244,383)
Income tax expense 1,927 310 2,733
Net loss (88,881) (226,539) (247,116)
Other comprehensive (loss) income:      
Foreign currency translation adjustment (776) 180 890
Unrealized gain (loss) on available for sale investments 360 1,131 (1,041)
Total other comprehensive (loss) income (416) 1,311 (151)
Net comprehensive loss $ (89,297) $ (225,228) $ (247,267)
Earnings per share, basic (in usd per share) $ (0.43) $ (1.18) $ (1.33)
Earnings per share, diluted (in usd per share) $ (0.43) $ (1.18) $ (1.33)
Weighted average shares outstanding, basic (in shares) 206,696 192,198 185,908
Weighted average shares outstanding, diluted (in shares) 206,696 192,198 185,908